New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 4, 2012
08:31 EDTCERSCerus signs purchase agreement for deployment of INTERCEPT Blood System
Cerus announced that it has signed a two-year purchase agreement with two regional Swiss Red Cross Blood Services for deployment of the INTERCEPT Blood System for plasma in Lausanne and Zurich. These two pilot centers supply an estimated 15,000 plasma units annually. The INTERCEPT platelet system is currently used by all 13 Swiss Red Cross blood centers. Switzerland produces approximately 35,000 platelet units and 50,000 plasma units for transfusion annually.
News For CERS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
08:12 EDTCERSCerus' Intercept supplier Ash Stevens receives FDA facility approval
Ash Stevens, a provider of global contract pharmaceutical drug substance development and Active Pharmaceutical Ingredient manufacturing services, received approval from the FDA for its manufacturing facility in Riverview, Michigan for the manufacture of Amotosalen, the API in Cerus' INTERCEPT Blood System. The INTERCEPT Blood System recently received FDA approval for ex vivo preparation of pathogen-reduced plasma and platelet components in order to reduce the risk of transfusion-transmitted infection.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use